Protein Drugs Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Protein Drugs Market
Protein Drugs Market: By Type (Antibody Drugs, Peptide Hormones, Blood Products, and Enzymes) & By Geography (Europe, Asia Pacific, North America, Rest of the World) - Forecast(2018 - 2023)
Report Code : HCR 0354
Updated Date: 16 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Protein Drugs Market – Market Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Protein Drugs Market– Market Forces
   4.1. Drivers
      4.1.1. Development the arena of proteomics and nanotechnology
      4.1.2. Growing incidences of chronic and autoimmune diseases
   4.2. Restraints
      4.2.1. Higher cost of research and development  
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Protein Drugs Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Protein Drugs Market, By Type
   6.1. Antibody Drugs
   6.2. Peptide Hormones
   6.3. Blood Products
   6.4. Enzymes 
7. Protein Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Protein Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Eli Lilly
   9.2. Abbott Laboratories
   9.3. UCB Group
   9.4. Schering-Plough Corporation
   9.5. Genentech Inc.
   9.6. Johnson & Johnson
   9.7. Bristol-Myers Squibb
   9.8. Novo Nordisk
   9.9. Biogen Idec
   9.10. Dendreon Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
There is a shift in focus from molecular drugs to protein based drugs in pharmaceutical industry. Protein drugs are artificially synthesized protein used in treatment of chronic diseases such as cancer, diabetes and CVD. Globally, development the arena of proteomics and nanotechnology, rising incidences of chronic and autoimmune diseases, rise in the awareness among people regarding protein drugs, increasing focus on research and development process, development in drug delivery system, and advantages of protein based drugs such as, high specificity, enhanced efficacy, affinity, solubility, and low incidences of toxicity are the prime growth drivers of protein drugs market. In addition, increase in adoption of protein drugs in emerging economies such as China, India and others, will create new opportunities for global protein drugs market. However, higher cost of the research and development, and complex government approval processes are the key restraints for protein drugs market.

 Protein Drugs Market

Geographically North America dominated global protein drugs market, with approximately half of the market in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing population chronic and autoimmune diseases patient in developing nations such as China, and India in this region. Among all the types, antibody segment has the highest market share in global protein drugs market due to higher prevalence of cancer patients.

This report identifies the global protein drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global protein drugs market.

This report segments global protein drugs market on the basis of type and regional market as follows:
  • Protein Drugs Market, By Type: Antibody Drugs, Peptide Hormones, Blood Products, and Enzymes
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the protein drugs market. Some of the major companies’ profiles in detail are as follows:
  • Eli Lilly
  • Abbott Laboratories
  • UCB Group
  • Schering-Plough Corporation
  • Genentech Inc.
List of Tables:

Table 1: Protein Drugs Market Overview 2017-2023
Table 2: Protein Drugs Market Leader Analysis 2017-2018 (US$)
Table 3: Protein Drugs Market Product Analysis 2017-2018 (US$)
Table 4: Protein Drugs Market End User Analysis 2017-2018 (US$)
Table 5: Protein Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Protein Drugs Market Financial Analysis 2017-2018 (US$)
Table 7: Protein Drugs Market Driver Analysis 2017-2018 (US$)
Table 8: Protein Drugs Market Challenges Analysis 2017-2018 (US$)
Table 9: Protein Drugs Market Constraint Analysis 2017-2018 (US$)
Table 10: Protein Drugs Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Protein Drugs Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Protein Drugs Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Protein Drugs Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Protein Drugs Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Protein Drugs Market Value Chain Analysis 2017-2018 (US$)
Table 16: Protein Drugs Market Pricing Analysis 2018-2023 (US$)
Table 17: Protein Drugs Market Opportunities Analysis 2018-2023 (US$)
Table 18: Protein Drugs Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Protein Drugs Market Supplier Analysis 2017-2018 (US$)
Table 20: Protein Drugs Market Distributor Analysis 2017-2018 (US$)
Table 21: Protein Drugs Market Trend Analysis 2017-2018 (US$)
Table 22: Protein Drugs Market Size 2017 (US$)
Table 23: Protein Drugs Market Forecast Analysis 2018-2023 (US$)
Table 24: Protein Drugs Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: Protein Drugs Market By Type, Revenue & Volume, By Antibody Drugs, 2018-2023 ($)
Table 27: Protein Drugs Market By Type, Revenue & Volume, By Peptide Hormones, 2018-2023 ($)
Table 28: Protein Drugs Market By Type, Revenue & Volume, By Blood Products, 2018-2023 ($)
Table 29: Protein Drugs Market By Type, Revenue & Volume, By Enzymes, 2018-2023 ($)
Table 30: North America Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 31: South america Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 32: Europe Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 33: APAC Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 34: Middle East & Africa Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 35: Russia Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 36: Israel Protein Drugs Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 37: Top Companies 2017 (US$)Protein Drugs Market, Revenue & Volume
Table 38: Product Launch 2017-2018Protein Drugs Market, Revenue & Volume
Table 39: Mergers & Acquistions 2017-2018Protein Drugs Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Protein Drugs Market 2017-2023
Figure 2: Market Share Analysis for Protein Drugs Market 2017 (US$)
Figure 3: Product Comparison in Protein Drugs Market 2017-2018 (US$)
Figure 4: End User Profile for Protein Drugs Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Protein Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Protein Drugs Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Protein Drugs Market 2017-2018
Figure 8: Ecosystem Analysis in Protein Drugs Market 2017
Figure 9: Average Selling Price in Protein Drugs Market 2017-2023
Figure 10: Top Opportunites in Protein Drugs Market 2017-2018
Figure 11: Market Life Cycle Analysis in Protein Drugs Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeProtein Drugs Market Revenue, 2018-2023 ($)
Figure 13: Global Protein Drugs Market - By Geography
Figure 14: Global Protein Drugs Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global Protein Drugs Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 17: US Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP – Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 24: Mexico Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 25: Mexico GDP and Population, 2017-2018 ($)
Figure 26: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 27: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 28: South America Protein Drugs Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 29: Brazil Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil GDP and Population, 2017-2018 ($)
Figure 31: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 32: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 33: Venezuela Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 34: Venezuela GDP and Population, 2017-2018 ($)
Figure 35: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 36: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 37: Argentina Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 38: Argentina GDP and Population, 2017-2018 ($)
Figure 39: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 40: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 41: Ecuador Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 42: Ecuador GDP and Population, 2017-2018 ($)
Figure 43: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 44: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 45: Peru Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 46: Peru GDP and Population, 2017-2018 ($)
Figure 47: Peru GDP – Composition of 2017, By Sector of Origin
Figure 48: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 49: Colombia Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 50: Colombia GDP and Population, 2017-2018 ($)
Figure 51: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 52: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 53: Costa Rica Protein Drugs Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 54: Costa Rica GDP and Population, 2017-2018 ($)
Figure 55: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 56: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 57: Europe Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 58: U.K Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 59: U.K GDP and Population, 2017-2018 ($)
Figure 60: U.K GDP – Composition of 2017, By Sector of Origin
Figure 61: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 62: Germany Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 63: Germany GDP and Population, 2017-2018 ($)
Figure 64: Germany GDP – Composition of 2017, By Sector of Origin
Figure 65: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 66: Italy Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 67: Italy GDP and Population, 2017-2018 ($)
Figure 68: Italy GDP – Composition of 2017, By Sector of Origin
Figure 69: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 70: France Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 71: France GDP and Population, 2017-2018 ($)
Figure 72: France GDP – Composition of 2017, By Sector of Origin
Figure 73: France Export and Import Value & Volume, 2017-2018 ($)
Figure 74: Netherlands Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 75: Netherlands GDP and Population, 2017-2018 ($)
Figure 76: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 77: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 78: Belgium Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 79: Belgium GDP and Population, 2017-2018 ($)
Figure 80: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 81: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 82: Spain Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 83: Spain GDP and Population, 2017-2018 ($)
Figure 84: Spain GDP – Composition of 2017, By Sector of Origin
Figure 85: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 86: Denmark Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 87: Denmark GDP and Population, 2017-2018 ($)
Figure 88: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 89: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 90: APAC Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 91: China Protein Drugs Market Value & Volume, 2018-2023
Figure 92: China GDP and Population, 2017-2018 ($)
Figure 93: China GDP – Composition of 2017, By Sector of Origin
Figure 94: China Export and Import Value & Volume, 2017-2018 ($)Protein Drugs Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 95: Australia Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 96: Australia GDP and Population, 2017-2018 ($)
Figure 97: Australia GDP – Composition of 2017, By Sector of Origin
Figure 98: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 99: South Korea Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 100: South Korea GDP and Population, 2017-2018 ($)
Figure 101: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 102: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 103: India Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 104: India GDP and Population, 2017-2018 ($)
Figure 105: India GDP – Composition of 2017, By Sector of Origin
Figure 106: India Export and Import Value & Volume, 2017-2018 ($)
Figure 107: Taiwan Protein Drugs Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 108: Taiwan GDP and Population, 2017-2018 ($)
Figure 109: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 110: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 111: Malaysia Protein Drugs Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 112: Malaysia GDP and Population, 2017-2018 ($)
Figure 113: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 114: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 115: Hong Kong Protein Drugs Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 116: Hong Kong GDP and Population, 2017-2018 ($)
Figure 117: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 118: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 119: Middle East & Africa Protein Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 120: Russia Protein Drugs Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia GDP and Population, 2017-2018 ($)
Figure 122: Russia GDP – Composition of 2017, By Sector of Origin
Figure 123: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 124: Israel Protein Drugs Market Value & Volume, 2018-2023 ($)
Figure 125: Israel GDP and Population, 2017-2018 ($)
Figure 126: Israel GDP – Composition of 2017, By Sector of Origin
Figure 127: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 128: Entropy Share, By Strategies, 2017-2018* (%)Protein Drugs Market
Figure 129: Developments, 2017-2018*Protein Drugs Market
Figure 130: Company 1 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 131: Company 1 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 132: Company 1 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 133: Company 2 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 134: Company 2 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 135: Company 2 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 136: Company 3 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 137: Company 3 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 138: Company 3 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 139: Company 4 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 140: Company 4 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 141: Company 4 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 142: Company 5 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 143: Company 5 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 144: Company 5 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 145: Company 6 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 146: Company 6 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 147: Company 6 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 148: Company 7 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 149: Company 7 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 150: Company 7 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 151: Company 8 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 152: Company 8 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 153: Company 8 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 154: Company 9 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 155: Company 9 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 156: Company 9 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 157: Company 10 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 158: Company 10 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 159: Company 10 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 160: Company 11 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 161: Company 11 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 162: Company 11 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 163: Company 12 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 164: Company 12 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 165: Company 12 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 166: Company 13 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 167: Company 13 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 168: Company 13 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 169: Company 14 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 170: Company 14 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 171: Company 14 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 172: Company 15 Protein Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 173: Company 15 Protein Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 174: Company 15 Protein Drugs Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll